Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™

URLhttps://www.stocktitan.net/news/OCGN/ocugen-secure
SourceStock Titan
Date Published06/15/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Jubilant HollisterStier
Parent companyJubilant Pharma Limited
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Reshoring
Year reshoring announced:2021
Domestically, the work will be done:Both
City reshored to:Spokane
State(s) reshored to:WA
If relevant, work nearshored to:-
Industry(ies):Chemicals, Biopharmaceutical
Product(s) reshoredbiopharmaceuticals, COVAXIN™, COVID-19 vaccine
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Lead time/Time to market, Under-utilized capacity, Other, import replacement, Covid-19
Find Reshoring Articles